Table 4.
Clinical and Dosimetric | Nominal Multivariate Regression Analysis |
|||
---|---|---|---|---|
Characteristic | OR (95%CI) | LogWorth | FDR p-value | |
V61 of GHM ≥ 18.57% | No | 1 | 3.932 | 0.00012* |
Yes | 32.8 (5.69–335) | |||
V55 of SPC ≥ 97.46% | No | 1 | 2.773 | 0.0017* |
Yes | 10.9 (2.7–57.5) | |||
Treatment Modalities | CCRT Only | 1 | 1.723 | 0.0189* |
IC+CCRT | 10.64 (2.27–65.72) | |||
RT alone | 0.79 (0.005–19.02) | |||
T Stage | 0–2 | 1 | 1.279 | 0.0526 |
3–4 | 5.29 (1.16–28.58) | |||
RT Dose | 1 (1.0002–1.009) | 1.279 | 0.0526 | |
Baseline DIGEST | 0–1 | 1 | 0.517 | 0.3037 |
2–3 | 1 (0.36–42.9) |
BIC=101.6, AICc=81.09, AUC=0.909